In his regular PharmaTimes feature, sustainability columnist Joe Newcombe looks out to pharma’s cleaner, greener horizon.
Chlorofluorocarbons (CFCs) first entered human use in the late 1920s and were popularised in the 1930s as ‘miracle refrigerants’.
CFCs found myriad uses, including as propellants for products from whipped cream to pressurised metered dose inhalers (pMDIs). By the 1980s, however, they were found to be contributing to a sizeable hole in Earth’s ozone layer. Adulation turned to vilification, and production of CFCs was essentially halted entirely in 2010 under the terms of the Montreal Protocol.
Read the full column in PharmaTimes.
See Joe's other PharmaTimes columns.
|
As featured in
|
